Series C Medical Companies

Endovascular Engineering develops and deploys advanced clot removal solutions for the treatment of venous thromboembolism.

Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.

Turquoise provides a transaction efficiency platform utilized by healthcare organizations to streamline payment processes.

XCath is a Houston-based stealth healthcare company.

Cognito Therapeutics develops neurotechnology therapies to treat neurodegenerative diseases by stimulating specific brain activity patterns.

Science is a clinical-stage medical technology company that develops neuroengineering systems to address neurological and sensory disorders.

ANEUVO is a platform therapy development company focused on development of disruptive neuromodulation technologies.

Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.

Elumn8 Medical is to use advancements in automation, intelligence, and visualization to address clinically unmet requirements

Solace connects patients with professional healthcare advocates that supports them through complex medical journeys.

Contrea is an It consulting firm that develops and operates tools that connects medical professionals and patients.

Inquis Medical is developing thrombectomy technology, enabling an efficient single-pass thrombectomy with minimal blood loss.

Docquity develops a health technology platform that provides access to a network of medical experts and content from industry pioneers.

Akura Medical is developing a next-generation thrombectomy device that aims to simplify thrombectomy through an easy-to-use.

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment of Circulatory Shock.

Venture Med Group develops medical devices for vascular health, focusing on peripheral artery disease and arteriovenous access treatment.

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Felix is a digital healthcare company providing seamless access to medication through online diagnoses and delivery.

Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.

MarvelBiome focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications.

Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology.

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

Fullpower-AI® is the provider of a deep learning generative AI sensing platform.